National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

About | Ordering | New

Menu menu

| Items in cart [0]

The National Academies Press

PAPERBACK
price:$39.00
add to cart

Rights & Permissions

topleft topright

Immunization Safety Review: Vaccines and Autism (2004)
Board on Health Promotion and Disease Prevention (HPDP)
 Institute of Medicine (IOM)

Citation Manager

. "Appendix D: Chronology of Important Events Regarding Vaccine Safety." Immunization Safety Review: Vaccines and Autism. Washington, DC: The National Academies Press, 2004.

Please select a format:

BibTeX EndNote RefMan
Page
191
bottomleft bottomright
  E-mail
Share on facebook Facebook
Share on delicious Delicious
Share on stumbleupon Stumble
Share on twitter Twitter
More Sharing ServicesMore

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.

Immunization Safety Review: Vaccines and Autism

Year

Vaccine Licensure

Legislation and/or Policy Statements

IOM Reports on Vaccine Safety

2002

 

 

Immunization Safety Review: Multiple Immunizations and Immune Dysfunction

Immunization Safety Review: Hepatitis B Vaccine and Demyelinating Neurological Disorders

Immunization Safety Review: SV40 Contamination of Polio Vaccine and Cancer

2003

Live attenuated intranasal influenza vaccine approved for use in the United States in healthy individuals aged 5-49 years old (FluMist)

ACIP recommends that children 6 to 23 months of age be vaccinated annually against influenza beginning in the 2004-2005 influenza season

Immunization Safety Review: Hepatitis B Vaccine and Demyelinating Neurological Disorders

Immunization Safety Review: SV40 Contamination of Polio Vaccine and Cancer

Immunization Safety Review: Vaccinations and Sudden Unexpected Death in Infancy

2004

 

 

Immunization Safety Review: Influenza Vaccines and Neurological Complications
Page
191